Biocept, Inc.
Biocept, Inc., a leading molecular diagnostics company headquartered in the United States, specialises in the development of innovative liquid biopsy technologies. Founded in 2011, Biocept has made significant strides in the oncology sector, focusing on the detection and monitoring of cancer through its proprietary assays. The company’s core offerings include its advanced circulating tumour cell (CTC) and circulating tumour DNA (ctDNA) tests, which provide critical insights for personalised cancer treatment. Biocept's unique approach to liquid biopsies sets it apart in the competitive landscape, enabling non-invasive testing that enhances patient care. With a strong market position, Biocept has achieved notable milestones, including partnerships with major healthcare institutions and a growing portfolio of intellectual property. As it continues to expand its operational reach, Biocept remains committed to advancing cancer diagnostics and improving patient outcomes.
DitchCarbon Score
How does Biocept, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Biocept, Inc.'s score of 18 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Biocept, Inc.'s reported carbon emissions
Biocept, Inc., headquartered in the US, currently does not have any publicly available carbon emissions data for the most recent year, nor do they have specified reduction targets or initiatives outlined in their climate commitments. Without specific emissions figures or reduction strategies, it is challenging to assess their environmental impact or commitment to climate action. As the industry increasingly prioritises sustainability, it is essential for companies like Biocept to establish clear climate goals and transparency regarding their carbon footprint.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Biocept, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
